The Indian maker of a cough syrup that was linked to the death of 19 children in Uzbekistan said on Friday that it had halted production of all medicines after an inspection by the drug regulator.

Indian media reported that the inspectors had found a deviation from rules on manufacturing at one of Marion Biotech's units. Neither Marion Biotech or India's health ministry immediately responded to a Reuters request for comment on the media reports or the findings of the inspection.

Uzbekistan's health ministry said at least 18 children died in Samarkand city after consuming Marion Biotech's Dok-1 Max syrup. Uzbek media on Thursday reported a 19th victim, with the death of a one-year-old child.